Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Co-Diagnostics Inc
CODX | US
2.11
USD-0.22
-9.44%
CODX | US
About Co-Diagnostics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
06/03/2026
Close
2.11
Open
2.05
High
2.33
Low
2.05
Co-Diagnostics Inc. a molecular diagnostics company develops manufactures and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19 influenza tuberculosis hepatitis B and C human papillomavirus malaria chikungunya dengue and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases liquid biopsy for cancer screening and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City Utah.
View LessCODX | US
Risk
61.2
Sharpe
-0.30
Luna's Score
46/100
Recommendation
Hold
Luna says (CODX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
70.1%1 month
61.2%3 months
174.2%6 months
420.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
16.00
Price to book
0.56
Debt to equity
0.04
Debt to assets
0.03
Ent. to EBITDA
0.52
Ent. to rev.
0.12
PEG
-
Other Fundamentals
EBITDA
-37.42M
MarketCap
67.33M
MarketCap(USD)
67.33M
Div. yield
-
Op. margin
-289.06
Erngs. growth
30.80
Rev. growth
1.24K
Ret. on equity
-42.73
Short ratio
1.43
Short perc.
0.68
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.44
Range1M
0.79
Range3M
6.18
Volumes: Market Activity
Rel. volume
0.32
Price X volume
4.45K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.52 | 12.67 | Cheaper |
| Ent. to Revenue | 0.12 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.56 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 174.15 | 59.59 | Riskier |
| Debt to Equity | 0.04 | -14.36 | Expensive |
| Debt to Assets | 0.03 | 0.34 | Cheaper |
| Market Cap | 67.33M | 13.71B | Emerging |
